Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mapemid XL 1.5mg tablets
0202010P0BKAAAD
|
Mapemid | Indapamide | Cardiovascular System | No data available |
|
Maprotiline 10mg tablets
0403010S0AAAAAA
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 25mg tablets
0403010S0AAABAB
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 50mg tablets
0403010S0AAAEAE
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 75mg tablets
0403010S0AAADAD
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maraviroc 150mg tablets
0503010ADAAAAAA
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 20mg/ml oral solution sugar free
0503010ADAAACAC
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 25mg tablets
0503010ADAAAEAE
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 300mg tablets
0503010ADAAABAB
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 75mg tablets
0503010ADAAADAD
|
Maraviroc | Maraviroc | Infections | No data available |
|
Marcain 0.25% with Adrenaline 50microg/10ml inj amp
1502010C0BBAFAI
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Marcain 0.5% with Adrenaline 50microg/10ml inj amp
1502010C0BBAGAJ
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Marevan 500microgram tablets
0208020V0BBAFAS
|
Marevan | Warfarin sodium | Cardiovascular System | No data available |
|
Marigold petals tincture
190606000BCUUA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Marol 100mg modified-release tablets (Morningside)
040702040BNAAAC
|
Marol | Tramadol hydrochloride | Central Nervous System | No data available |
|
Marol 200mg modified-release tablets (Morningside)
040702040BNACAE
|
Marol | Tramadol hydrochloride | Central Nervous System | No data available |
|
Marshmallow root tincture
190606000BCUCA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Masidemen 50mg/200microgram gastro-resistant tablets
1001010C0CPAAAM
|
Masidemen | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Masidemen 75mg/200microgram gastro-resistant tablets
1001010C0CPABAX
|
Masidemen | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Mastaflu vacc inj 0.5ml pre-filled syringes
1404000H0BJAAAF
|
Mastaflu | Influenza | Immunological Products and Vaccines | No data available |
|
Matever 250mg tablets
0408010A0BCADAA
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Matever 500mg tablets
0408010A0BCACAB
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Matever 500mg/5ml concentrate for inf vials
0408010A0BCAEAJ
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Matever 750mg tablets
0408010A0BCABAI
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Mavenclad 10mg tablets
0802040AYBBAAAA
|
Mavenclad | Cladribine (Immunomodulating) | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.